These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response. Chess L, Bock GN, Ungaro PC, Buchholz DH, Mardiney MR. J Natl Cancer Inst; 1973 Jul 14; 51(1):57-65. PubMed ID: 4720886 [No Abstract] [Full Text] [Related]
12. Temporary suppression of lymphocyte transformation after tuberculin skin testing. Thestrup-Pedersen K. Immunology; 1974 Dec 14; 27(6):965-71. PubMed ID: 4452577 [Abstract] [Full Text] [Related]
16. Intrinsic lymphocyte defect in Hodgkin's disease: analysis of the phytohemagglutinin dose-response. Ziegler JB, Hansen P, Penny R. Clin Immunol Immunopathol; 1975 Mar 14; 3(4):451-60. PubMed ID: 803886 [No Abstract] [Full Text] [Related]
17. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination]. Yildirim C, Küçük AI, Ongüt G, Oğünç D, Colak D, Mutlu G. Mikrobiyol Bul; 2009 Jan 14; 43(1):27-35. PubMed ID: 19334377 [Abstract] [Full Text] [Related]
18. Comparison of the biologic activity of tuberculins by the use of lymphocyte cultures. Nilsson BS, Magnusson M. Am Rev Respir Dis; 1973 Sep 14; 108(3):565-70. PubMed ID: 4745252 [No Abstract] [Full Text] [Related]
19. [Immune responses in patients with neoplasms of the mouth cavity]. Mazeron JJ, Eschwege F, Schneider M. Nouv Presse Med; 1980 Nov 08; 9(42):3185. PubMed ID: 7443474 [No Abstract] [Full Text] [Related]